Oncodesign Precision Medicine (OPM) and Servier Announce a S

Identification and validation of new therapeutic targets against pancreatic cancer - Building a common Artificial Intelligence (AI) analytical platform - Generation and sharing of clinical and biological

Related Keywords

Paris , France General , France , French , Mathilde Bohin Louis Victor Delouvrier , Philippe Genne , Coexya Lyon , Arthur Rouill , Walids Kamoun , Oncodesign Dijon , Acobiom Montpellier , Jean Philippe Stephan , Instagram , Linkedin , Servier In Vitro Pharmacology Research Unit , Twitter , Facebook , Servier Group , Artificial Intelligence , Drug Discovery , Oncodesign Precision Medicine , Pancreatic Ductal Adenocarcinoma , Vitro Pharmacology Research Unit , Precision Medicine , Chief Executive Officer , Bohin Louis Victor Delouvrier , Oncodesign , Precision , Medicine , Servier , Nnounce , Strategic , Collaboration , Discover , Herapeutic , Targets , Pancreatic , Dancer , Treatment ,